April 16, 2016
A jury's finding that two Amgen patents for a cholesterol drug were valid can't stand, rival Sanofi told a Delaware federal court in a motion Friday, saying the claims of the patents are overbroad and insufficiently described.
March 16, 2016
A Delaware federal jury found that two Amgen Inc. patents for a cholesterol drug were valid, handing the California-based pharmaceutical giant victory over rivals Sanofi SA and Regeneron Pharmaceuticals Inc., Amgen said Wednesday.